Medical device companies will have an easier time getting paid for innovative technologies under two policy changes announced by Medicare agency head Seema Verma.
The changes are part of the Trump administration’s push to inject more technology and innovation into the health-care system that can improve patient outcomes and lower costs.
One new Centers for Medicare & Medicaid Services policy will allow device makers two opportunities a year to apply for permanent procedure codes for new devices, compared with the current system’s one shot per year, Verma said at the Medical Device Manufacturers Association’s annual meeting May 2. The codes ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.